Cargando…
Novel Therapeutic Approaches to Invasive Candidiasis: Considerations for the Clinician
Invasive candidiasis (IC), due to the yeast pathogen Candida, is still a major cause of in-hospital morbidity and mortality. The limited number of antifungal drug classes and the emergence of multi-resistant Candida species, such as Candida auris and some Candida glabrata isolates, is concerning. Ho...
Autor principal: | Lamoth, Frederic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968438/ https://www.ncbi.nlm.nih.gov/pubmed/36855391 http://dx.doi.org/10.2147/IDR.S375625 |
Ejemplares similares
-
Drug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis
por: Murphy, Sarah E., et al.
Publicado: (2021) -
Letter on “(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial”
por: Kritikos, Antonios, et al.
Publicado: (2021) -
Invasive Candidiasis in the Elderly: Considerations for Drug Therapy
por: Dekkers, B. G. J., et al.
Publicado: (2018) -
Atypical imaging patterns during lung invasive mould diseases: lessons for clinicians
por: Casutt, Alessio, et al.
Publicado: (2023) -
Diagnosis of invasive candidiasis in the ICU
por: Eggimann, Philippe, et al.
Publicado: (2011)